COMMUNIQUÉS West-GlobeNewswire

Aino Health AB (publ): Aino Health signs agreement with Attendo Finland
20/03/2019
2019-03-20 Aino Health has signed a contract with Attendo Finland regarding Aino's SaaS solution HealthManager. The order value of the agreement is, for the first year, SEK 800,000. The agreement is valid until further [...]
Novo Nordisk files oral semaglutide for US regulatory approval of glycaemic control, as well as for CV risk reduction for oral semaglutide and Ozempic®
20/03/2019
Bagsværd, Denmark, 20 March 2019 - Novo Nordisk today announced the submission of two New Drug Applications (NDAs) to the US Food and Drug Administration (FDA) for oral semaglutide, a once-daily glucagon-like peptide-1 [...]
Bio-Path Holdings Reports Full Year 2018 Financial Results
20/03/2019
Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, March 20, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi [...]
Aptevo Therapeutics Begins Phase 1 Clinical Trial of APVO210 a Novel Bispecific Antibody for the Treatment of Autoimmune and Inflammatory Diseases
20/03/2019
Unique Mechanism of Action Suppresses Inflammation and Immune Activation Without Promoting Pro-Inflammatory Lymphocyte Stimulation Preliminary Phase 1 Data Read-outs Anticipated Q3 and Q4 2019 SEATTLE, March 20, 2019 ( [...]
ATW Tech’s Subsidiary, Voxtel, Now Accepts Visa Debit and Mastercard Debit Payments on Its Unified Payment Solution
20/03/2019
MONTREAL, March 20, 2019 (GLOBE NEWSWIRE) -- ATW Tech Inc. (“ATW Tech” or the “Company”) (TSX-V: ATW) is pleased to announce that its subsidiary Voxtel now accepts Visa Debit and Mastercard Debit payment options as part [...]
La filiale d’ATW Tech, Voxtel, accepte les paiements par Visa Débit et Mastercard Débit grâce à sa solution de paiement unifié
20/03/2019
MONTRÉAL, 20 mars 2019 (GLOBE NEWSWIRE) -- ATW Tech Inc. (" ATW Tech " ou la " Société ") (TSX-V : ATW) est heureuse d'annoncer que sa filiale Voxtel élargit sa gamme de produits et la clientèle adressable en acceptant [...]
Diffusion Pharmaceuticals Reports 2018 Financial Results and Provides Business Update
20/03/2019
Highlights Include FDA Approval of Phase 2 On-Ambulance Clinical Trial with TSC for the Treatment of Stroke and Continuation of Phase 3 Trial with TSC for Inoperable Glioblastoma Multiforme CHARLOTTESVILLE, Va., March [...]
LifeBridge Health Chooses Artifact Health to Streamline Physician Queries
20/03/2019
LifeBridge Health to implement Artifact solution across its four hospitals BOULDER, Colo., March 20, 2019 (GLOBE NEWSWIRE) -- Artifact Health , which provides the first and only mobile platform that streamlines the [...]
Tauriga Sciences Inc. Increases its Research & Development Budget to Continually Enhance its CBD Infused Chewing Gum Product Line
20/03/2019
New York, NY, March 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]
Driven Deliveries, Inc. to Present at the Sidoti & Company Spring 2019 Investor Conference
20/03/2019
SAN DIEGO, March 20, 2019 (GLOBE NEWSWIRE) -- Driven Deliveries, Inc. (DRVD), the world’s first and only publicly traded cannabis delivery company, announced today that they will be presenting at the Sidoti & [...]
Amgen, Cytokinetics and Servier Announce Continuation of GALACTIC-HF Following Planned Interim Analysis
20/03/2019
Data Monitoring Committee Recommends Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure to Continue Without Changes THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif. and SURESNES, France, [...]
Menlo Therapeutics Announces New Board Member Elisabeth Sandoval
20/03/2019
REDWOOD CITY, Calif., March 20, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), [...]
Lantos Technologies Launches the Only FDA-Cleared 3D Ear Scanning System
20/03/2019
Innovative Technology Breaks the Mold and Enables Audiologists to Modernize Their Practice, Unlocks Personalized Hearing Solutions for Patients WILMINGTON, Mass., March 20, 2019 (GLOBE NEWSWIRE) -- Lantos Technologies [...]
March of Dimes and AMAG Pharmaceuticals, Inc., Announce First Joint Supportive Pregnancy Care Program
20/03/2019
First Site Launches in Springfield, Mass. Offering an Innovative Model of Group Prenatal Care ARLINGTON, Va. and WALTHAM, Mass., March 20, 2019 (GLOBE NEWSWIRE) -- March of Dimes and AMAG Pharmaceuticals, Inc. (NASDAQ: [...]
The Joint Corp. to Present at the Cowen and Company 5th Annual Future of the Consumer Conference
20/03/2019
SCOTTSDALE, Ariz., March 20, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced that management is scheduled to attend the Cowen and [...]
BioSyent Releases Results for Fourth Quarter and Full Year 2018
20/03/2019
TORONTO, March 20, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and twelve months ended December 31, 2018. Key highlights include: [...]
Spectral Expands its Renal Replacement Therapy Development Program to Include the Home Dialysis Market
20/03/2019
TORONTO, March 20, 2019 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a Phase III company developing the first treatment for patients with endotoxemic septic shock guided by a [...]
Solo Growth Announces Licensing Agreement and Acquisition of Call Right on Operating Retail Cannabis Store in Red Deer, Alberta
20/03/2019
CALGARY, Alberta, March 20, 2019 (GLOBE NEWSWIRE) -- Solo Growth Corp.™ (the “ Company ” or “ Solo Growth ”) (TSXV: SOLO) is pleased to announce that it has entered into and closed a definitive agreement, effective [...]
Fibrocell to Host Conference Call & Webcast for Full Year 2018 Financial Results and Recent Highlights on March 27, 2019
20/03/2019
- Company to provide update on Type B meeting with FDA on Phase 3 clinical trial design for FCX-007 gene therapy candidate for recessive dystrophic epidermolysis bullosa (RDEB) - - Company to highlight updated data from [...]

Pages